CD151 and adenocarcinoma: Given the strong association between CD151 and lung cancer (Tokuhara et al., 2001; Kwon et al., 2013), especially adenocarcinoma which is the most common NSCLC subtype, CD151 expression has proven to be especially informative on patient prognosis.